Identifying low cancer-specific mortality risk lymph node-positive radical prostatectomy patients.
Francesco BarlettaStefano TapperoSimone MorraReha-Baris IncesuCristina Cano GarciaMattia L PiccinelliLukas ScheipnerZhe TianGiorgio GandagliaArmando StabileElio MazzoneCarlo TerroneNicola LongoDerya TilkiFelix K H ChunOttavio de CobelliSascha AhyaiFred SaadShahrokh F ShariatFrancesco MontorsiAlberto BrigantiPierre I KarakiewiczPublished in: Journal of surgical oncology (2024)
Lymph node-positive RP patients exhibit variable CSS rates. Within this heterogeneous group, those at very low risk of CSM may be identified based on pathological characteristics, namely ISUP GG1-3, pT2-3a, and 1-2 positive lymph nodes. Such stratification scheme might be of value for individual patients counseling, as well as in design of clinical trials.
Keyphrases
- lymph node
- end stage renal disease
- ejection fraction
- clinical trial
- newly diagnosed
- prostate cancer
- chronic kidney disease
- radical prostatectomy
- prognostic factors
- squamous cell carcinoma
- early stage
- randomized controlled trial
- neoadjuvant chemotherapy
- sentinel lymph node
- radiation therapy
- young adults
- study protocol
- open label